Selenium sulfide disrupts the PLAGL2/C‐MET/STAT3‐induced resistance against mitochondrial apoptosis in hepatocellular carcinoma
Abstract Background Hepatocellular carcinoma (HCC) is the third leading cause of cancer‐related deaths worldwide. Overexpression of pleomorphic adenoma gene like‐2 (PLAGL2) is associated with tumorigenesis. However, its function in HCC is unclear, and there are currently no anti‐HCC drugs that targe...
Guardado en:
Autores principales: | Tianfeng Yang, Jian Huo, Rui Xu, Qi Su, Wenjuan Tang, Dongdong Zhang, Man Zhu, Yingzhuan Zhan, Bingling Dai, Yanmin Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/769b517ae0a34af99893265a8d4ff97b |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Orthogonal MET analysis in a population‐representative stage II–III colon cancer cohort: prognostic and potential therapeutic implications
por: Stephanie G. Craig, et al.
Publicado: (2021) -
Improving selenium status in plant nutrition and quality
por: Mora,M.L, et al.
Publicado: (2015) -
The impact of STAT3 and phospho-STAT3 expression on the prognosis and clinicopathology of ovarian cancer: a systematic review and meta-analysis
por: Shuo Gao, et al.
Publicado: (2021) -
Selenium as a pleiotropic agent for medical discovery and drug delivery
por: Guan BZ, et al.
Publicado: (2018) -
Uses of Selenium Nanoparticles in the Plant Production
por: Iqra Bano, et al.
Publicado: (2021)